Loading organizations...
Transcend Medical is a technology company.
Transcend Medical Communications operates as a full-service scientific medical communications firm, delivering strategic promotional education initiatives globally. The company specializes in translating complex scientific and clinical data into accessible and engaging content for various healthcare stakeholders. Its comprehensive offerings ensure that pharmaceutical and medical device innovations are effectively communicated to target audiences worldwide.
Information about the founders, founding date, and the specific insight that led to the company's creation is not readily available from the provided sources. The firm emerged to address the growing demand for specialized expertise in communicating scientific advancements within the highly regulated healthcare landscape, responding to the critical need for clear and impactful medical discourse.
Transcend Medical Communications serves clients across the pharmaceutical and medical device industries, supporting their efforts to educate healthcare professionals and patients alike. The company's vision centers on becoming the premier partner for scientific dissemination, ensuring that critical medical information reaches the right audiences efficiently and accurately, thereby advancing healthcare knowledge and patient outcomes globally.
Transcend Medical has raised $131.0M across 4 funding rounds.
Transcend Medical has raised $131.0M in total across 4 funding rounds.
High-Level OverviewTranscend Medical, also known as Transcend CPAP, is a medical technology company specializing in portable, travel-friendly CPAP (Continuous Positive Airway Pressure) devices designed for individuals with sleep apnea. Their flagship product is a lightweight, compact CPAP machine that incorporates patented technologies such as Capillary Force Vaporizer™ (CFV) for heated humidification and heat moisture exchange (HME) to improve user comfort. Transcend serves patients requiring sleep therapy, especially those who travel or have active lifestyles, addressing the problem of bulky, inconvenient traditional CPAP machines. The company has demonstrated strong growth momentum by pioneering innovations in portable sleep therapy and securing FDA clearances and industry awards since its founding in 2010[2][3].
Origin StoryTranscend CPAP was founded in 2010 by Somnetics International Inc., a Minnesota-based medical device company focused on respiratory medical devices. The idea emerged from the need to overcome the limitations of conventional CPAP machines, which are often bulky and inconvenient for travel. Early traction came from being the first to design a travel CPAP with lightweight portable batteries and power accessories, including solar chargers, and integrating patented humidification technology. The company quickly gained FDA market clearance and received notable industry awards in 2011 and 2012, establishing its reputation for innovation in sleep apnea therapy[2][3].
Core Differentiators- Product Differentiators: The Transcend CPAP is the smallest and lightest portable CPAP device globally, weighing less than one pound, with quiet, vibration-free air-bearing blower technology.- Innovative Humidification: Uses patented Capillary Force Vaporizer™ (CFV) technology and heat moisture exchange (HME) for effective humidification in a compact form.- Power Flexibility: Offers rechargeable battery packs (4-cell and 8-cell) and mobile power options including solar chargers, enabling use in remote locations and during power outages.- User Experience: Designed for ultimate portability and ease of use, allowing patients to maintain therapy regardless of travel or lifestyle constraints.- Regulatory and Market Validation: FDA clearance and multiple awards for product differentiation in the sleep-disordered breathing market[2][3].
Role in the Broader Tech LandscapeTranscend Medical rides the growing trend of portable, patient-centric medical devices that enhance therapy adherence and quality of life. As aging populations and increasing awareness of sleep apnea drive demand for effective treatment, the timing is ideal for portable CPAP solutions that integrate advanced technology with user convenience. Market forces such as rising travel and outdoor lifestyles, combined with the need for uninterrupted therapy, favor Transcend’s innovations. The company influences the broader ecosystem by setting new standards for portability and user-friendly design in respiratory therapy devices, encouraging further innovation in medical device miniaturization and power autonomy[2][3].
Quick Take & Future OutlookLooking ahead, Transcend Medical is well-positioned to expand its market share by continuing to innovate in portable sleep therapy technology and power solutions. Trends such as telemedicine, remote patient monitoring, and increasing demand for personalized healthcare devices will likely shape their journey. Their influence may grow as they integrate more connectivity features and data analytics to enhance therapy outcomes. Maintaining leadership in portability and user experience will be critical as competition intensifies. Overall, Transcend’s pioneering approach to travel CPAP devices ties back to its mission of enabling uninterrupted, comfortable sleep therapy anywhere, anytime[2][3].
Transcend Medical has raised $131.0M in total across 4 funding rounds.
Transcend Medical's investors include Canaan Partners, Frazier Healthcare Partners, InterWest, Finistere Ventures, HLM Venture Partners, Investor Growth Capital, Kaiser Permanente Ventures, Latterell Venture Partners, mag, Split Rock Partners, Technology Partners, Morgenthaler Ventures.
Transcend Medical has raised $131.0M across 4 funding rounds. Most recently, it raised $29.0M Series C in April 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2014 | $29.0M Series C | Canaan Partners, Frazier Healthcare Partners, InterWest, Canaan Partners, Finistere Ventures, HLM Venture Partners, Investor Growth Capital, Kaiser Permanente Ventures, Latterell Venture Partners, mag, Split Rock Partners, Technology Partners | |
| Jan 1, 2012 | $16.0M Series B | Canaan Partners, Frazier Healthcare Partners, InterWest | |
| Jul 15, 2011 | $51.0M Series B | Canaan Partners, Finistere Ventures, HLM Venture Partners, Investor Growth Capital, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners, Technology Partners | |
| May 1, 2009 | $35.0M Series B | Canaan Partners, Frazier Healthcare Partners, InterWest |